Galmed Pharmaceuticals:子公司资助授权专利持续费用的义务将于7月31日终止

美股速递
Jul 30

Galmed Pharmaceuticals 宣布,其子公司为授权专利相关的持续性费用提供资金支持的义务,将自7月31日起正式终止。这一重大变化,意味着相关专利费用的财务负担将迎来显著调整。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10